Journal of the American Academy of Dermatology
Volume 62, Issue 3 , Pages 387-392 , March 2010

Hydroxychloroquine and lichen planopilaris: Efficacy and introduction of Lichen Planopilaris Activity Index scoring system

  • Charles Chiang, MD

      Affiliations

    • Department of Dermatology at University of California, San Francisco, California
  • ,
  • Deborah Sah, MD

      Affiliations

    • Palo Alto Medical Foundation, Fremont Center, Fremont, California
  • ,
  • Bryan K. Cho, MD

      Affiliations

    • Department of Dermatology at Palo Alto Medical Foundation, Camino Medical Group, Mountain View, California
  • ,
  • Blanca E. Ochoa

      Affiliations

    • Department of Dermatology at Baylor College of Medicine, Houston, Texas
  • ,
  • Vera H. Price, MD

      Affiliations

    • Department of Dermatology at University of California, San Francisco, California
    • Corresponding Author InformationReprint requests: Vera H. Price, MD, Department of Dermatology at University of California, San Francisco, 1701 Divisadero St, Third Floor, San Francisco, CA 94143.

,Accepted 14 August 2009.

References 

  1. Olsen E, Bergfeld W, Cotsarelis G, Price V, Shaprio J, Sinclair R, et al. Summary of North American Hair Research Society (NAHRS)-sponsored workshop on cicatricial alopecia, Duke University Medical Center, February 10 and 11, 2001. J Am Acad Dermatol. 2003;48:103–110
  2. Ochoa B, King L, Price V. Lichen planopilaris: annual incidence in four hair referral centers in the United States. J Am Acad Dermatol. 2008;58:352–353
  3. Shapiro J. Cicatricial alopecias. Dermatol Ther. 2008;21:211
  4. Harries M, Sinclair R, Macdonald-Hull S, Whiting D, Griffiths C, Paus R. Management of primary cicatricial alopecias: options for treatment. Br J Dermatol. 2008;159:1–22
  5. Chieregato C, Zini A, Barba A, Magnanini M, Rosina P. Lichen planopilaris: report of 30 cases and review of the literature. Int J Dermatol. 2003;42:342–345
  6. Mehregan D, Van Hale H, Muller S. Lichen planopilaris: clinical and pathologic study of forty-five patients. J Am Acad Dermatol. 1992;27:935–942
  7. Cervasco N, Bergfeld W, Remzi B, de Knott H. A case-series of 29 patients with lichen planopilaris: the Cleveland Clinic Foundation experience on evaluation, diagnosis, and treatment. J Am Acad Dermatol. 2007;57:47–53
  8. Templeton S, Solomon A. Scarring alopecia: a classification based on microscopic criteria. J Cutan Pathol. 1994;21:97–109
  9. Tan E, Martinka M, Ball N, Shapiro J. Primary cicatricial alopecias: clinicopathology of 112 cases. J Am Acad Dermatol. 2004;50:25–32
  10. Kossard S. Postmenopausal frontal fibrosing alopecia: scarring alopecia in a pattern distribution. Arch Dermatol. 1994;130:770–774
  11. Tan K, Messenger A. Frontal fibrosing alopecia: clinical presentation and prognosis. Br J Dermatol. 2009;160:75–79
  12. Kalia S, Dutz J. New concepts in antimalarial use and mode of action in dermatology. Dermatol Ther. 2007;20:160–174
  13. Marmor MF, Carr RE, Easterbrook M, Farjo AA, Mieler WF. American Academy of Ophthalmology. Recommendations on screening for chloroquine and hydroxychloroquine retinopathy: a report by the American Academy of Ophthalmology. Ophthalmology. 2002;109:1377–1382
  14. Marmor MF. New American Academy of Ophthalmology recommendations on screening for hydroxychloroquine retinopathy. Arthritis Rheum. 2003;48:1764
  15. Levy G, Munz S, Paschal J, Cohen H, Pince K, Peterson T. Incidence of hydroxychloroquine retinopathy in 1,207 patients in a large multicenter outpatient practice. Arthritis Rheum. 1997;40:1482–1486
  16. Mirmirani P, Willey A, Price VH. Short course of oral cyclosporine in lichen planopilaris. J Am Acad Dermatol. 2003;49:667–671
  17. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33:159–174

 Funding sources: None.

 Conflicts of interest: None declared.

PII: S0190-9622(09)01211-0

doi: 10.1016/j.jaad.2009.08.054

Journal of the American Academy of Dermatology
Volume 62, Issue 3 , Pages 387-392 , March 2010